Why the study?
Are lower plasma concentrations of adiponectin associated with the development of acute coronary syndrome in patients with coronary artery disease?
Population
140 participants, including 123 patients with coronary artery disease and 17 control participants.
Comparison
Measurement of plasma concentrations of… vs Control participants without CAD, and…
Design
Case-control
Authors
Loading...
Lower adiponectin was associated with ACS; hypothesis-generating for biomarker use in CAD, pending prospective validation.
Are lower plasma concentrations of adiponectin associated with the development of acute coronary syndrome in patients with coronary artery disease?
Lower plasma concentrations of adiponectin are independently associated with the development of acute coronary syndrome, suggesting its potential utility as a biomarker for CAD risk assessment.
Yasuhiro Nakamura (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: